Mystbio
Latest round
- Angel
Last raised
- Feb 2026
Total raised
- Undisclosed
Investors
- 1
About Mystbio
, trading under the name Mystbio, provides molecular diagnostic and medical data solutions for the healthcare industry. The company works with healthcare providers and clinical institutions to provide diagnostic solutions for oncology. Product offerings include the OncoMUSE platform for oncology diagnostics and therapeutic insights, along with specialized algorithms like the irAEs preemptive assessment algorithm, the Aging Clock algorithm and the Precision Nutrition algorithm. The company generates revenue from the direct sale of molecular diagnostic reagents to hospitals, cancer centers, and clinical laboratories.
Who invested in Mystbio
1 investor across 1 round
See all investors in Mystbio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Feb 26, 2026
Amount
Undisclosed
Investors
Questions about Mystbio
Who invested in Mystbio?
Mystbio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mystbio raised?
Mystbio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mystbio last raise money?
Mystbio's most recent round on record is a Angel, in Feb 2026.
What does Mystbio do?
, trading under the name Mystbio, provides molecular diagnostic and medical data solutions for the healthcare industry.
Where is Mystbio headquartered?
Mystbio is headquartered in Beijing, China.
Which VCs invest in companies like Mystbio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at Mystbio's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Angel
Raising like Mystbio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.